章青, 傅深. The role of intraoperatve radiotherapy in the management of breast cancer[J]. China Oncology, 2013, 23(8): 590-595. DOI: 10.3969/j.issn.1007-3969.2013.08.005.
The role of intraoperatve radiotherapy in the management of breast cancer
Breast cancer is the most common disease in women worldwide
which not only threatened the women’s survival time
but also influenced their quality of life as well. Within this challenge
it’s important to optimize the current multidisciplinary treatment stratagem for breast cancer. Radiotherapy is one of the most important treatment modality for patients with breast cancer
with the trend to shrink the irradiated volume and shorten the total fraction times in recent years. Intraoperative radiation therapy (IORT) as a fast and convenient procedure has the ability to deliver a high
single-fraction radiation dose to tumor beds with minimal exposure of surrounding tissues (lung
heart
etc.)
which could be displaced or shielded right after the tumor removal during the surgical procedure. Right now
IORT has been either integrated as a boost technique in multimodal approaches using postoperative EBRT in the treatment of early breast cancer patients undergoing breast conservation surgery or used as a single dose accelerated partial breast irradiation technique for these patients. This review discussed the rationale of IORT
the benefits and limitations of IORT
the indication and the clinical results of this procedure
including treatment related side-effects as well in order to provide the preliminary evidence based approach for early breast cancer patients.
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives
A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China
Impact of miR-193a-3p on migration and invasion of breast cancer stem cells through targeting TRIM14
Axillary management after neoadjuvant therapy for breast cancer and optimization of sentinel lymph node diagnosis and treatment
Related Author
The Society of Breast Cancer China Anti-Cancer Association
Breast Oncology Group of the Oncology Branch of the Chinese Medical Association
LU Ye
ZHANG Wenxiang
KONG Xiangyi
FANG Yi
WANG Jing
GAO Jidong
Related Institution
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases
Department of Laboratory Medicine, Xingtai People’s Hospital